CAMBRIDGE, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (FULC) ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...
CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (FULC) ® (NASDAQ: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback